GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Boditech Med 206640.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

8,800

-1.12%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Boditech Med

Its shares trade on KOSDAQ under the ticker 206640.KQ. It has been listed since 29 December 2014. In the fiscal year to 31 December 2025, it reported revenue of ₩162.09bn and net income of ₩23.65bn. At that date it held total assets of ₩281.63bn and shareholders' equity of ₩231.28bn.

Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2014-12-29. The firm is engaged in the manufacture and sale of antigen diagnostic kits and other products. In addition, the Company is engaged in the manufacture and sale of cancer diagnostic kit, drug concentration diagnostic kit and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 1998 and is located in Chuncheon-si, Gang-won-do, South Korea.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
29 Dec 2014

Leadership

Pay as last reported

  • Mr. Ui Yeol ChoiChief Executive Officer, Director, since 2015₩1.49bn
  • Mr. Seong Wuk JungAssistant Managing Director
  • Mr. Jeong Jun HwangAssistant Managing Director
  • Mr. Yong Hwan ByunNon-Executive Independent Director, since 2011
  • Mr. Sang Gyu ParkNon-Executive Independent Director
  • Mr. Yin Beom SeoNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Boditech Med Inc manufactures antigen diagnostic kits for domestic and overseas markets.
  • The company has been established since 1998, providing stability in the Health Care sector.
  • Boditech Med Inc offers cancer diagnostic kits and drug concentration diagnostic kits.

Weaknesses

  • The company's products are limited to in-vitro diagnostics analyzers and reagents.
  • Boditech Med Inc relies on domestic market sales for a significant portion of revenue.
  • The firm has no mention of international expansion beyond current overseas markets.

Opportunities

  • Growing demand for cancer diagnostic kits in South Korea's Health Care sector.
  • Expanding overseas markets for antigen diagnostic kits and reagents.
  • Increasing need for drug concentration diagnostic kits in medical facilities.

Threats

  • Competition from other in-vitro diagnostics companies in South Korea.
  • Economic downturns affecting healthcare spending in domestic markets.
  • Regulatory changes in the Health Care industry impacting product approvals.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.